TLV •
Healthcare •
Biotechnology •
Quote as of 09/10/2026
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeTLV
Market Capitalization40.31 mln
Float44.09 mln
Piotroski F-Score
3
/ 9
Below average
Relative Strength
93
/ 100
Top performer
Debt / Equity
1.27
Elevated leverage
Pre-Tax Margin
-1,199%
Severely loss-making
ROE
-46.77
Deeply negative
ROA
-21.00
Deeply negative
Business Description
Clal Biotechnology Industries is a Tel Aviv-based investment firm founded in 1998 that funds life sciences companies across all stages of growth, from early-stage startups to more mature businesses. The firm focuses on medical devices, biopharmaceuticals, and biotechnology, targeting companies in Israel and the United States. It typically takes an active role as a lead investor and board member, investing through its management's own capital.
